You can now read 5 articles in a month for free on Read as much as you want anywhere and anytime for just 99¢.

Vertex Pharma.

Continue reading below

Cambridge biotech company Vertex Pharmaceuticals Inc. paid its departing chief executive, Matthew W. Emmens, $13.3 million last year, down from $14.9 million in 2010, according to a regulatory filing. His compensation included a $1.1 million salary, an incentive plan payment of $3 million, and stock and option grants totaling $9.1 million. He stepped down Feb. 1. Jeffrey Leiden took over the job.

Loading comments...

Wake up with today's top stories.

Want each day's news headlines delivered fresh to your
inbox every morning? Just connect with us
in one of the following ways:
Please enter a valid email will never post anything without asking.
Privacy Policy
Subscriber Log In

You have reached the limit of 5 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of
Marketing image of